Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
A phase 3 trial of [18F]FAPI-74 PET/CT in oesophageal cancer and gastric & gastro-oesophageal junction cancer, run by SOFIE, now recruiting.
Overview
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer. is a phase 3 interventional study registered as NCT07217704 by SOFIE, with 200 participants planned, started 2025-11-14 and due to reach its primary completion in 2027-08-30. Interventions recorded: [18F]FAPI-74 PET/CT.
Similar pages
not linked directly; found by shared links- TrialA Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With Advanced Gastric or Gastroesophageal Junction Cancer
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer and the tag pipeline.
- Trial64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer and the tag pipeline.
- TrialA First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer and the tag pipeline.
- TrialSL-28 for Advanced Solid Tumours
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer and the tag pipeline.
- TrialA Study of MT-4561 in Patients With Various Advanced Solid Tumors
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer and the tag pipeline.
- TrialDose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer and the tag pipeline.
- TrialFeasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer and the tag pipeline.
- TrialPhase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer and the tag pipeline.